Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholonergic system

• Κύριοι συγγραφείς: Farsalinos, Konstantinos, Niaura, Raymond, Le Houezec, Jacques, Barbouni, Anastasia, Tsatsakis, Aristidis, Kouretas, Dimitrios, Vantarakis, Apostolos, Poulas, Konstantinos
• Άλλοι συγγραφείς: Φαρσαλινός, Κωνσταντίνος
• Γλώσσα: English
• Έκδοση: Elsevier 2020
• Θέματα: SARS-CoV-2; COVID-19; ACE2; inflammation; smoking; nicotine; hospitalization

COVID-19 is a disease caused by a novel coronavirus, SARS-CoV-2. On March 23 we presented evidence of a low prevalence of smoking among hospitalized patients with COVID-19 in China, and we were the first to establish the hypothesis that nicotine may be beneficial for COVID-19 and should be evaluated...